Dalfoni Banerjee is an award-winning serial entrepreneur and consultant. Beginning her career over 25 years ago in academic, pharmaceutical, and start-up biotechnology research laboratories, she went on to lead inspection-readiness efforts, drive clinical research and clinical operations, manage relationships between pharma and key opinion leaders, develop marketing strategies/tactics, and launch new drug products – across 12+ therapeutic categories. In 2023, Dalfoni founded ImmuNovX Biotech, a company that is developing an innovative technology that rapidly generates antigens for use in veterinary and human vaccines. For this endeavor, she brought onboard an experienced leadership team, 8 expert advisors, and 15 graduate students. In 2011, Dalfoni founded 3Sixty Pharma Solutions, with a mission to partner with start-up and established pharmaceutical, biotechnology, and medical device companies to help accelerate development & de-risk assets. Dalfoni is a mentor and trusted advisor to entrepreneurs, life-science organizations, start-up incubators, and university innovation and technology transfer offices, serves on the Merck Sharp & Dohme Federal Credit Union Board of Directors, is an invited speaker and moderator on a variety of industry-related topics, has authored and co-authored several publications, and has received over 30 awards.